Filing Details

Accession Number:
0001177648-21-000027
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-13 18:39:01
Reporting Period:
2021-10-08
Accepted Time:
2021-10-13 18:39:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1177648 Enanta Pharmaceuticals Inc ENTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1646976 Nathalie Adda C/O Enanta Pharmaceuticals, Inc.
500 Arsenal Street
Watertown MA 02472
Sr. Vp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-10-08 13,453 $43.46 40,397 No 4 M Direct
Common Stock Disposition 2021-10-08 13,453 $70.09 26,944 No 4 S Direct
Common Stock Acquisiton 2021-10-11 4,047 $43.46 30,991 No 4 M Direct
Common Stock Disposition 2021-10-11 4,047 $70.34 26,944 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-10-08 13,453 $0.00 13,453 $43.46
Common Stock Stock Option (Right to Buy) Disposition 2021-10-11 4,047 $0.00 4,047 $43.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
58,817 2025-06-29 No 4 M Direct
54,770 2025-06-29 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in May 2021.
  2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.30, inclusive.
  3. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $70.05 to $70.85, inclusive.
  4. 100% of the shares subject to the option are fully vested and exercisable.